2.7. Safety Evaluations
hematologic, blood chemistry, blood lipid
ADVERSE EVENT, PATHOLOGY
Safety evaluations of test products included monitoring of AEs, conducting clinical pathology tests (e.g., hematologic, blood chemistry, blood lipid, and urine tests), measuring vital signs (e.g., pulse and blood pressure), checking physical measurements (body weight), and analyzing electrocardiogram results for abnormal findings throughout the study.Adverse events were assessed throughout the study. Follow-up was conducted on all AEs until they disappeared, stabilized, or became definable symptoms.